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Member States now have to 
communicate to the Commission 
the national legal measures they 
take to comply with the provisions 
of the directive.
John Dalli, Commissioner for Health 
and Consumer Policy said: “March  
represents a landmark in our efforts 
to protect public health in the EU. 
The ban clearly demonstrates our 
determination to offer the highest 
possible level of health protection to 
our citizens.
Despite the fact that there are 
uncertainties concerning the 
harmfulness of the exposure of infants 
to Bisphenol A, the Commission 
deemed it both necessary and 
appropriate to take action. The aim 
is to further reduce the exposure 
of the most vulnerable part of our 
population – i.e. the infants – to the 
substance thus safeguarding their 
health”.
A ban prohibiting the manufacture in 
the European Union of baby bottles 
containing the potentially hazardous 
Bisphenol A (BPA) substance enters 
into force on  March.
BPA is an organic molecule that 
is used in the manufacture of 
polycarbonate plastics, widely 
employed to manufacture plastic 
materials, such as baby bottles.
Small amounts of BPA can be released 
from plastic containers such as baby 
bottles into the food they carry if 
these containers are heated at high 
temperatures.
According to scientific evidence, 
infants’ ability to eliminate BPA is 
still building up during their first six 
months of life. Their exposure to the 
substance is thus the highest during 
this period, especially if infant 
formula administered through such 
baby bottles is their only source of 
nutrition. 
The ban of the manufacture of baby 
bottles with BPA was adopted in 
January (EU Directive (20/8/EU) 
and enters into force on  March. In 
addition the ban will be extended 
on  June 20 to the placing on the 
market and the import into the EU of 
baby bottles containing BPA.
In parallel, the industry is voluntarily 
withdrawing from the market 
baby bottles containing BPA and 
replacing them with safer products. 
This withdrawal is expected to be 
completed by mid 20.
Ban of Bisphenol A in baby bottles
2EU consumers could save about €3 
billion in total in electricity bills
A European Commission study on the EU 
retail electricity markets shows that EU 
consumers could save about €3 billion 
in total in electricity bills if they switched 
to the cheapest electricity tariff they 
could find. Individually, consumers could 
save about €00 if they switched to the 
cheapest offer. 
Mystery shoppers conducting the study 
have indeed been able to find a less 
expensive tariff in more than six cases out 
of ten (62%). 
This study is a follow-up to the findings of 
the 2009 Consumer Markets Scoreboard, 
which found the retails electricity market 
to be amongst the worst performing 
markets for consumers. The study also 
shows that consumers are not making 
full use of the savings opportunities 
that market liberalisation has created, 
allowing them a choice of electricity 
suppliers:
As next step, the Commission envisages a 
series of actions to improve the situation, 
including the following:
The full text of the study is available at:
http://ec.europa.eu/consumers/strategy/
facts_en.htm#Energy
In brief
Further information is available at: 
http://europa.eu/rapid/pressReleasesAction.
do?reference=MEMO/ /64&format=HTML&aged=0
&language=EN&guiLanguage=en
(http://www.iarc.fr), were developed 
with the input of over 90 experts from 
32 countries, and set a benchmark 
for best practice in colorectal 
cancer screening. Widespread 
application of the Guidelines should 
also make it easier for experts in 
the field to exchange information 
and experience across the EU. This 
is essential for innovation and 
continuous quality improvement 
of existing cancer screening 
programmes. 
The European Commissioner for 
Health and Consumer Policy John 
Dalli said: “These guidelines on 
screening help to give patients a 
chance of receiving timely treatment 
thanks to early diagnosis of colorectal 
cancer. For patients, screening and 
diagnosis can make the difference 
between life and death. This is why 
it is important that these guidelines, 
and the benchmark for best practice 
in colorectal cancer screening which 
they set, are indeed followed widely 
across the EU”.
The European Guidelines for Quality 
Assurance in Colorectal Cancer 
Screening and Diagnosis is available 
at the EU Book Shop website or 
through the following link:
http://ec.europa.eu/health/major_
chronic_diseases/diseases/cancer/
index_en.htm#fragment3
On 3 February, on the eve of the 
World Cancer Day, the European 
Commission published the first 
edition of the “European Guidelines 
for Quality Assurance in Colorectal 
Cancer Screening and Diagnosis”.
Colorectal cancer is the second most 
common newly diagnosed cancer 
in the EU. It is also the second most 
common cause of cancer death in 
the EU, accounting for one in seven 
new cancers and one in eight cancer 
deaths. Improving diagnosis and 
screening is therefore key to reduce 
the mortality rates.
The EU Guidelines on colorectal 
cancer screening aim to raise 
quality standards by providing 
guiding principles and evidence-
based recommendations on quality 
assurance which should be followed 
when implementing colorectal 
screening programmes in the EU 
Member States. They cover the 
entire screening process - from 
invitation and organisation, through 
to diagnosis and management of 
lesions detected. 
The publication provides indeed the 
first ever set of uniform guidelines on 
all the steps necessary for effective 
colorectal cancer screening in the 
EU. By implementing them, Member 
States have the potential to organise 
their health systems more effectively, 
including the diagnosis and 
management of cancers detected 
in screening. There is good evidence 
that population-based screening 
using the EU-recommended test 
reduces mortality from colorectal 
cancer by around 5% in people 
of appropriate age (50 to 74 years) 
invited to attend screening.
The guidelines, coordinated for the 
Commission by the International 
Agency for Research on Cancer 
New EU Guidelines on Colorectal 
Cancer Screening and Diagnosis
- Very few consumers switch electricity 
suppliers: switching rates are above 0% 
in only seven EU countries; 
- Less than a third of EU consumers (32%) 
have compared offers from different 
suppliers; 
- 4% of consumers do not know if they 
can find a cheaper tariff for themselves; 
- Less than half of EU consumers (47%) 
know how much electricity they 
consume.
- National regulators will develop 
guidelines for providing information to 
consumers more effectively, for making 
it easier to compare prices and to switch 
suppliers; 
- Jointly with key stakeholders, the 
Commission will identify best practices 
in alternative dispute resolution in the 
energy sector;
- The Commission will promote 
better energy bills and complaint 
handling via the implementation of 
the recommendations already in place, 
including those developed by the 
Citizen’s Energy Forum.
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Rare Disease Day 20: focus on 
health inequalities
The last day of February is the 
International Rare Disease Day. 28 
February 20 marked the fourth edition 
of the event. This is an awareness-raising 
event coordinated by EURORDIS, the 
European Organisation for Rare Diseases, 
at international level and by national 
alliances of patient organisations at 
national level. On this occasion, hundreds 
of patient organisations from more 
than 40 countries worldwide organised 
awareness-raising activities and 
converged around the slogan “Rare but 
Equal”.
Patient groups and their partners, 
coordinated by national alliances at 
country level, planned a multitude of 
events to draw attention to rare diseases 
and the millions of people who are 
affected by them. Awareness-raising 
activities were carried out across Europe, 
in Russia, Georgia and Armenia, as well as 
in the US, Canada, Australia, New Zealand, 
China and Japan. Furthermore, a book 
entitled “The voice of 2.000 patients” 
and several videos were made available 
on the website of the event.
Rare diseases are life-threatening or 
chronically debilitating diseases with a low 
prevalence and a high level of complexity. 
A disease or disorder is defined as rare in 
Europe when it affects less than  in 2000 
citizens. It is estimated that there are 6000 
to 8000 rare diseases in the world today, 
75% affecting children.
The national healthcare services for 
diagnosis, treatment and care of rare 
disease patients differ significantly in 
terms of their availability and quality. 
Paola Testori Coggi, European 
Commission’s Director-General for Health 
and Consumers said: “I would like to 
express my wholehearted support for 
World Rare Diseases Day. It is vital that 
we continue to raise awareness of the 
difficulties faced by those affected. Even 
though only around 7% of Europeans 
suffer from a rare disease, this translates 
to around 36 million people. Rare diseases 
are a prime example of where working at 
European level can prove to be immensely 
beneficial. A Eurobarometer survey 
published to mark World Rare Diseases 
Day illustrates that most Europeans 
agree”.
Further information is available at:
http://www.rarediseaseday.org/
In brief
The consultation paper is available at:
http://ec.europa.eu/consumers/redress_cons/collec-
tive_redress_en.htm
On 4 February, the European 
Commission launched a public 
consultation aimed at achieving 
a coherent approach towards 
collective redress in the European 
Union. Contributions can be sent 
until 30 April 20.
Collective redress is not a new 
concept in the EU. Current EU law 
already provides for the possibility 
of pursuing collective actions for 
injunctions in the field of consumer 
law, but the national legal systems 
vary considerably concerning 
financial markets, competition, 
environmental protection, and 
other areas of law. The situation is 
even more diverse among Member 
States when several consumers or 
businesses want to seek damages in 
the same case. Injunctive collective 
redress (aimed at stopping illegal 
behaviour) is indeed a normal feature 
in the EU’s consumer legislation, 
but as regards collective actions for 
damages (also called compensatory 
actions), some Member States have 
them, while others do not.
The Commission will therefore 
attempt to identify common legal 
principles that should underpin 
collective actions across the EU by 
launching this horizontal public 
consultation entitled: “Towards a 
more coherent European approach 
to collective redress”. The purpose 
of this consultation is to identify 
common legal principles, should 
a future Commission initiative be 
presented on collective redress. 
The Commission will consider all 
views to identify whether collective 
redress may or may not be a suitable 
subject for EU legislation, taking into 
account the principles of subsidiarity, 
proportionality and effectiveness. A 
hearing will be held to complete the 
consultation. The Commission will 
then publish a Communication on the 
results. The final decision on whether 
new EU legislation is needed will be 
based on the consultation’s outcome 
and, if appropriate, after a detailed 
impact assessment exploring all 
possible actions.
than 200 entries. The coverage of 
the feed materials listed in the new 
Catalogue is significantly increased 
and simultaneously the information 
about their properties is improved. 
Feed information will soon 
improve significantly, thus further 
empowering feed users, due to a rare 
act of private-sector cooperation that 
resulted in a Commission proposal, 
which was endorsed by the Member 
States at the Standing Committee 
for on the Food Chain and Animal 
Health (SCoFCAH).
The private sector worked voluntarily 
on a ground-breaking update 
of the old list of feed materials 
(Catalogue), which contains less 
A renewed Catalogue for better 
feed information
Commission seeks opinions on the 
future of collective actions
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European Parliament paves the 
way for protection of citizens from 
Falsified Medicines
The European Parliament voted 
favourably in its first reading on the 
proposed new EU legislation on falsified 
medicines on 6 February. Falsified 
Medicines are fake medicines that 
pass themselves off as real, authorised 
medicines. Falsified medicines may 
contain ingredients, including active 
ingredients, which are of low quality or 
in the wrong dosage - either too high 
or too low. Since they have not passed 
through the necessary evaluation of 
quality, safety and efficacy as required by 
the EU authorisation procedure, they can 
be a major health threat.
The Directive aims at preventing falsified 
medicines from reaching the patients by 
introducing harmonised, pan-European 
safety and control measures. These 
measures will ensure easier identification 
of falsified medicines, and improved 
verifications and controls at EU borders 
and within the EU.
It also addresses the sale of falsified 
medicines over the internet. The Directive 
provides indeed for an obligatory 
“trust mark” on the websites of legally-
operating online pharmacies.
Once the Council will have adopted this 
new EU legislation, it will have to be 
transposed by each Member State into 
its national law within 8 months and 
is going to apply as of then. In parallel, 
the Commission will work on various 
measures to implement and supplement 
the legislation.
Commissioner for Health and Consumer 
Policy John Dalli said: “I welcome this 
vote on a Directive that will increase the 
protection our citizens from the dangers 
of falsified medicines and I congratulate 
and thank the Rapporteur, Ms. Marisa 
Matias, for all her work. I look forward to 
a swift implementation of this Directive 
by the Member States”.
Further information is available at: 
http://ec.europa.eu/health/human-use/
quality/fake-medicines/index_en.htm
EP news
ND-CV--003-EN-N
The Hungarian Presidency will host 
a high-level conference entitled “For 
a Healthy Future of Our Children 
– Childhood immunization” in 
Budapest on 3-4 March 20. The 
goal of the conference is to increase 
awareness about the importance 
of achieving and maintaining high 
childhood immunization coverage, 
in order to strengthen the prevention 
and control of vaccine preventable 
disease. Commissioner Dalli will 
address the audience with opening 
remarks by a video message.
On the occasion of this conference, the 
impact of childhood immunization 
across EU will be discussed and 
experiences from efforts to reach 
under-vaccinated populations 
will be shared. The conference will 
review cross-border issues related 
to childhood immunization, and 
strategies for vaccinating mobile 
and difficult-to-reach children will 
be identified. The event will also aim 
at exploring further opportunities 
for EU collaboration on childhood 
immunization.
Senior national public health experts, 
including national immunization 
programme managers and national 
epidemiologists from the EU and the 
European Economic Area (EEA) and 
EU candidate/potential candidate 
countries, as well as representatives 
of professional associations and 
non-governmental organisations 
will take part to the event.
The topics addressed by the 
conference are in line with the planned 
Commission’s initiative of a proposal 
for a Council Recommendation on 
cross-border aspects of childhood 
immunization. This initiative will aim 
at seeking a political commitment 
to strengthen and maintain high 
childhood vaccination coverage 
for priority vaccine preventable 
diseases, and will also provide 
recommendations to tackle the main 
causes of insufficient vaccination 
coverage.
Conference on Childhood 
Immunization in Budapest
Further information is available at:
http://www.eu20.hu
The new feed marketing rules came 
into effect on  September 200. 
Introducing the new approach of co-
regulation, all interested feed chain 
partners were given the chance to 
participate in the updating of the EU 
Catalogue of feed materials. Thirty-
eight EU associations of the feed 
sector presented their joint proposal 
shortly after the new regulation 
entered into force, proving their 
strong commitment in the mandate 
they received from the legislators 
and their belief in the added value 
of the Catalogue’s updating. 
In line with the co-regulation 
approach, the Commission checked 
the proposal, did some limited fine-
tuning and presented it for a vote in 
the animal nutrition section of the 
Standing Committee for on the Food 
Chain and Animal Health (SCoFCAH). 
The draft Regulation received a 
positive opinion by qualified majority 
and will now undergo the European 
Parliament and Council scrutiny 
before the Commission can officially 
approve it.
The regulation is expected to enter 
into force in the first half of 20.
Further information is available at:
http://ec.europa.eu/food/food/animalnutrition/label-
ling/index_en.htm
